News

Apnimed Reports Positive Topline Results From Second Phase 3 Trial Of AD109, Reinforcing Potential Of First Oral Pill For Obstructive Sleep Apnea
LunAIRo, Apnimed's second Phase 3 trial of AD109, met its primary endpoint, demonstrating a reduction in the Apnea-Hypopnea Index (AHI) f ...